Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of a DNA-labeling system for array-based comparative genomic hybridization.

Pauline T Lieu1, Peter Jozsi, Patrick Gilles

  • 1Invitrogen Life Technologies, 1610 Faraday Ave, Carlsbad, CA 92008, USA. Pauline.lieu@Invitrogen.com

Journal of Biomolecular Techniques : JBT
|July 21, 2005
PubMed
Summary

A new random prime genomic DNA labeling method enhances microarray comparative genomic hybridization (CGH) for cancer studies. This optimized method improves sensitivity and signal quality for detecting DNA copy-number variations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simulation Teaching Associates: a Model Utilizing Senior Medical Students as Simulation Educators.

Medical science educator·2024
Same author

Employing High-Fidelity Simulation for the High-Risk, Low-Frequency Diagnosis and Management of Acute Radiation Syndrome (ARS).

MedEdPORTAL : the journal of teaching and learning resources·2023
Same author

Results of a National Survey of Program Directors' Perspectives on a Pass/Fail US Medical Licensing Examination Step 1.

JAMA network open·2022
Same author

Disaster medicine and pandemic response: A novel curriculum to improve understanding of complex care delivery during the COVID-19 pandemic.

AEM education and training·2021
Same author

A Fixed, Unreducible, Unstable Medial Swivel Dislocation of the Talonavicular Joint with Associated Navicular Fracture.

Case reports in orthopedics·2021
Same author

EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease.

JBMR plus·2021

Area of Science:

  • Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • Chromosomal amplifications and deletions are key in tumorigenesis.
  • DNA copy-number variations correlate with mRNA expression changes.
  • Genome-wide microarray comparative genomic hybridization (CGH) detects chromosomal changes in tumors.

Purpose of the Study:

  • To develop an optimized random prime genomic DNA labeling method for enhanced array-based CGH analysis.
  • To improve sensitivity, signal-to-noise ratios, and reproducibility in CGH.
  • To facilitate the detection of subtle DNA copy-number variations.

Main Methods:

  • Developed a novel random prime genomic DNA labeling system using formulated primers, nucleotide mixtures, and a high concentration of exo-Klenow DNA polymerase.

Related Experiment Videos

  • Compared the optimized labeling method against standard random prime and nick translation methods using microarray analyses.
  • Utilized varying amounts of genomic DNA, including as little as 0.5 microg, for labeling.

    • Main Results:

    • The optimized labeling system yielded higher fluorescent intensities and improved signal-to-noise ratios compared to standard methods.
    • Detected more positive features, including twofold differences in gene copy number between male and female DNA.
    • Successfully identified amplifications and deletions in the BT474 breast cancer cell line.
    • Routine detection of copy-number alterations was achieved with minimal starting genomic DNA (0.5 microg).

    Conclusions:

    • The optimized random prime labeling method significantly enhances the sensitivity and resolution of array-based CGH.
    • This technique improves the detection of DNA copy-number variations crucial for cancer and medical genetic studies.
    • The method's flexibility and efficiency with different fluorescent labels make it broadly applicable.